Aurobindo Pharma’s Eugia Pharma Specialities IPO is going to create a buzz on Dalal Street very soon. The company has announced this Initial Public Offer to raise around ₹4,500 crore. After the news, stock market enthusiasts are curious to know its fundamentals and DRHP details before the IPO opening date. Aurobindo Pharma is one of the well-known pharmaceutical companies in India. This IPO is likely to hit the market in the upcoming months.
The Eugia Pharma Specialities IPO news has been unveiled by Moneycontrol on 11 January 2024. Eugia Pharma Specialities IPO offer for sale (OFS) and the fresh issue will be announced by the company soon or later. Till now there are some investment banks that the company has shortlisted for its initial public offer. The list of advisors includes several names Axis Capital, Jefferies, Kotak Mahindra Capital, and JP Morgan. Eugia Pharma Specialities is the subsidiary firm of Aurobindo Pharma.
Previously, the parent company was planning to sell the firm. However as per the officials of the company, now the plan is shifted to enter the public market and raise the funds through an IPO. In December, the company re-filed the papers of IPO to SEBI with a reduced size.
Now highlighting the financial stats and fundamentals of the company. We want to inform you that, the Eugia Pharma Specialities financials is yet to be available. Currently, the company is looking to get approval from SEBI.
The Aurobindo Pharma share price has risen amid the IPO of Eugia Pharma Specialities. The opening date and other important details will be available once the company gets approval for its IPO. If you are also excited about this IPo do let us know. Also, the grey market premium and other details will be available on our website soon and you can check the latest IPOs and business news on Industrial Front.